| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.019 | 0.8 |